Kidney Week

Educational Symposium

Advances in Inflammation Mechanisms and Therapies to Reduce Atherosclerotic Cardiovascular Disease in Persons with Kidney Diseases

October 25, 2024 | 06:45 AM - 07:45 AM

Location: Marriott Grand Ballroom 5, Marriott Marquis

Session Description

The leading cause of morbidity and mortality globally is atherosclerotic cardiovascular disease (ASCVD) related conditions, according to the American College of Cardiology. Systemic inflammation is linked to the development of atherosclerosis. Kidney diseases are associated with upregulation of inflammatory pathways, and inflammation may be an important mechanism in ASCVD and a novel therapeutic target in persons with kidney diseases.

This symposium addresses the pathophysiology of immune response, inflammatory risk, and anti-inflammatory treatments in patients with kidney diseases.

Support is provided by an educational grant from Novo Nordisk.

Learning Objective(s)

• Describe the pathophysiology of immune response in patients with kidney diseases
• Explain the intersection of inflammatory risk for atherosclerosis in kidney diseases
• Discuss current and emerging anti-inflammatory treatments in patients with kidney diseases

Learning Pathway(s)

• Hypertension and Cardiorenal Disorders
• CKD Non-Dialysis

Moderator

• Michel Chonchol, MD, FASN

Presentations

• Introduction
  06:45 AM - 06:55 AM
  
  • Michel Chonchol, MD, FASN

Introduction

October 25, 2024 | 06:45 AM - 06:55 AM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Inflammation as a Mechanism for ASCVD in Kidney Diseases
  06:55 AM - 07:15 AM
  
  • Steven D. Crowley, MD

Inflammation as a Mechanism for ASCVD in Kidney Diseases

October 25, 2024 | 06:55 AM - 07:15 AM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Advances in Therapies to Target Inflammation to Reduce Atherosclerosis in Kidney Diseases
  07:15 AM - 07:35 AM
  
  • Laura M. Dember, MD, FASN

Advances in Therapies to Target Inflammation to Reduce Atherosclerosis in Kidney Diseases

October 25, 2024 | 07:15 AM - 07:35 AM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Audience Q&A
  07:35 AM - 07:45 AM
  

Audience Q&A

October 25, 2024 | 07:35 AM - 07:45 AM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.